During the past decade, Università Cattolica S. Cuore, Ematologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Cattolica S. Cuore, Ematologia" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Università Cattolica S. Cuore, Ematologia" are "Non-Hodgkin's Lymphoma" (2 trials), "B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Classical Hodgkin Lymphoma" (1 trials) and "DLBCL" (1 trials). Many other conditions were trialed in "Università Cattolica S. Cuore, Ematologia" in a lesser frequency.

Most popular intervention types in "Università Cattolica S. Cuore, Ematologia" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Venetoclax" (3 trials), "CHOP" (2 trials), "Obinutuzumab" (2 trials), "Rituximab" (2 trials) and "rituximab [MabThera/Rituxan]" (2 trials). Other intervention names were less common.

The vast majority of trials in "Università Cattolica S. Cuore, Ematologia" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Università Cattolica S. Cuore, Ematologia". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Università Cattolica S. Cuore, Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Università Cattolica S. Cuore, Ematologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".